The surgical management of neuroendocrine tumour hepatic metastases

被引:17
作者
Pathak, S. [1 ]
Dash, I. [1 ]
Taylor, M. R. [1 ]
Poston, G. J. [2 ]
机构
[1] Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England
来源
EJSO | 2013年 / 39卷 / 03期
关键词
Hepatic; Neuroendocrine metastases; Liver; Surgery; Resection; LIVER METASTASES; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; THERMAL ABLATION; CRYOTHERAPY; THERAPIES;
D O I
10.1016/j.ejso.2012.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although rare in incidence, patients with neuroendocrine tumours (NET) live for many years and so have a high prevalence, and NETs frequently metastasise to the liver (NLM). Numerous treatment options have been implemented both for cure, and to implement disease control. Surgical treatment consists of curative resection, palliative cytoreductive resection and transplantation. Complete surgical resection is possible only in a subset of people with NLMs due to various factors. Ablative therapies may also be used, either as an adjunct to surgery or as a primary treatment. The purpose of the article is to summarise surgical treatment strategies in the management of patients with hepatic neuroendocrine metastases. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:224 / 228
页数:5
相关论文
共 40 条
  • [1] Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long-term follow-up
    Akyildiz, Hizir Yakup
    Mitchell, Jamie
    Milas, Mira
    Siperstein, Allan
    Berber, Eren
    [J]. SURGERY, 2010, 148 (06) : 1288 - 1293
  • [2] [Anonymous], 2000, HPB, DOI [DOI 10.1016/S1365-182X(17)30755-4, 10.1016/S1365-182X(17)30755-4]
  • [3] Treatment of neuroendocrine cancer metastatic to the liver: The role of ablative techniques
    Atwell, TD
    Charboneau, JW
    Que, FG
    Rubin, J
    Lewis, BD
    Nagorney, DM
    Callstrom, MR
    Farrell, MA
    Pitot, HC
    Hobday, TJ
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 28 (04) : 409 - 421
  • [4] Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin
    Auernhammer, Christoph J.
    Goeke, Burkhard
    [J]. GUT, 2011, 60 (07) : 1009 - 1021
  • [5] A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver
    Bhardwaj, N.
    Strickland, A. D.
    Ahmad, F.
    Atanesyan, L.
    West, K.
    Lloyd, D. M.
    [J]. PATHOLOGY, 2009, 41 (02) : 168 - 172
  • [6] Carcinoid tumour
    Caplin, ME
    Buscombe, JR
    Hilson, AJ
    Jones, AL
    Watkinson, AF
    Burroughs, AK
    [J]. LANCET, 1998, 352 (9130) : 799 - 805
  • [7] Open Surgical is Superior to Percutaneous Access for Radiofrequency Ablation of Hepatic Metastases
    Eisele, Robert M.
    Neumann, Ulf
    Neuhaus, Peter
    Schumacher, Guido
    [J]. WORLD JOURNAL OF SURGERY, 2009, 33 (04) : 804 - 811
  • [8] Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease
    Frilling, A.
    Li, J.
    Malamutmann, E.
    Schmid, K. -W.
    Bockisch, A.
    Broelsch, C. E.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (02) : 175 - 184
  • [9] Multimodal management of neuroendocrine liver metastases
    Frilling, Andrea
    Sotiropoulos, Georgios C.
    Li, Jun
    Kornasiewicz, Oskar
    Ploeckinger, Ursula
    [J]. HPB, 2010, 12 (06) : 361 - 379
  • [10] Long-term survival after surgical management of neuroendocrine hepatic metastases
    Glazer, Evan S.
    Tseng, Jennifer F.
    Al-Refaie, Waddah
    Solorzano, Carmen C.
    Liu, Ping
    Willborn, Katherine A.
    Abdalla, Eddie K.
    Vauthey, Jean-Nicolas
    Curley, Steven A.
    [J]. HPB, 2010, 12 (06) : 427 - 433